Darrel P. Cohen - 16 Aug 2023 Form 4 Insider Report for Viracta Therapeutics, Inc. (VIRX)

Signature
/s/ Daniel Chevallard, as Attorny-in-Fact
Issuer symbol
VIRX
Transactions as of
16 Aug 2023
Net transactions value
$0
Form type
4
Filing time
18 Aug 2023, 16:46:18 UTC
Previous filing
16 Aug 2023
Next filing
13 Mar 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRX Stock Option (Right to Buy) Award $0 +235,000 $0.000000 235,000 16 Aug 2023 Common Stock 235,000 $1.23 Direct F1
transaction VIRX Stock Option (Right to Buy) Award $0 +265,000 $0.000000 265,000 16 Aug 2023 Common Stock 265,000 $1.23 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Company's 2021 Inducement Equity Incentive Plan through each such date. The Vesting Commencement Date is August 7, 2023.
F2 Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Company's 2021 Equity Incentive Plan through each such date. The Vesting Commencement Date is August 7, 2023.